JP2020506715A5 - - Google Patents

Download PDF

Info

Publication number
JP2020506715A5
JP2020506715A5 JP2019543805A JP2019543805A JP2020506715A5 JP 2020506715 A5 JP2020506715 A5 JP 2020506715A5 JP 2019543805 A JP2019543805 A JP 2019543805A JP 2019543805 A JP2019543805 A JP 2019543805A JP 2020506715 A5 JP2020506715 A5 JP 2020506715A5
Authority
JP
Japan
Prior art keywords
seq
sequence shown
specific binding
amino acid
binding molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019543805A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020506715A (ja
JP7189142B2 (ja
Filing date
Publication date
Priority claimed from GBGB1702091.8A external-priority patent/GB201702091D0/en
Application filed filed Critical
Publication of JP2020506715A publication Critical patent/JP2020506715A/ja
Publication of JP2020506715A5 publication Critical patent/JP2020506715A5/ja
Application granted granted Critical
Publication of JP7189142B2 publication Critical patent/JP7189142B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019543805A 2017-02-08 2018-02-08 抗ヒトアネキシンa1抗体 Active JP7189142B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1702091.8 2017-02-08
GBGB1702091.8A GB201702091D0 (en) 2017-02-08 2017-02-08 Specific binding molecules
PCT/EP2018/053232 WO2018146230A1 (en) 2017-02-08 2018-02-08 Anti human annexin a1 antibody

Publications (3)

Publication Number Publication Date
JP2020506715A JP2020506715A (ja) 2020-03-05
JP2020506715A5 true JP2020506715A5 (https=) 2021-03-18
JP7189142B2 JP7189142B2 (ja) 2022-12-13

Family

ID=58462456

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019543805A Active JP7189142B2 (ja) 2017-02-08 2018-02-08 抗ヒトアネキシンa1抗体

Country Status (14)

Country Link
US (1) US11041019B2 (https=)
EP (1) EP3579875B1 (https=)
JP (1) JP7189142B2 (https=)
KR (1) KR102687512B1 (https=)
CN (1) CN110475570B (https=)
AU (1) AU2018219595B2 (https=)
BR (1) BR112019016160A2 (https=)
CA (1) CA3052903C (https=)
ES (1) ES3009440T3 (https=)
GB (1) GB201702091D0 (https=)
IL (1) IL268506A (https=)
MX (1) MX2019009382A (https=)
RU (1) RU2019126888A (https=)
WO (1) WO2018146230A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2580241B1 (en) 2010-06-09 2020-11-04 Queen Mary & Westfield College, University of London Annexin 1 antibody
GB201121564D0 (en) 2011-12-14 2012-01-25 Queen Mary & Westfield College Use of antibody
EP3448874A4 (en) 2016-04-29 2020-04-22 Voyager Therapeutics, Inc. COMPOSITIONS FOR TREATING A DISEASE
US11299751B2 (en) 2016-04-29 2022-04-12 Voyager Therapeutics, Inc. Compositions for the treatment of disease
GB201813137D0 (en) * 2018-08-10 2018-09-26 Medannex Ltd Cancer treatment with an antibody
CA3138550A1 (en) 2019-04-30 2020-11-05 Target Discovery Merger Sub II, LLC Cancer associated antibody compositions and methods of use
EP4061420A1 (en) * 2019-11-20 2022-09-28 Abvision, Inc. Monoclonal antibodies that target human cd47 protein
CN118465272B (zh) * 2019-12-04 2025-08-19 珠海泰诺麦博制药股份有限公司 抗人巨细胞病毒抗体及其用途
US20240124606A1 (en) * 2021-02-22 2024-04-18 Northwestern University Anti-cd73 monoclonal antibodies
CA3238416A1 (en) 2021-11-18 2023-05-25 Henry Charles Wilson HAYS Combination therapy for cancer
WO2025149667A1 (en) 2024-01-12 2025-07-17 Pheon Therapeutics Ltd Antibody drug conjugates and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8625941D0 (en) 1986-10-30 1986-12-03 Sandoz Ltd Substituted alpha-amino acids
US5051364A (en) 1989-02-16 1991-09-24 The Salk Institute For Biological Studies Anti-lipocortin-I and anti-lipocortin-II monoclonal antibodies
US5565338A (en) 1990-06-04 1996-10-15 La Jolla Institute For Allergy And Immunology Suppressor T-cell hybridoma and production of allergen specific glycosylation inhibiting factor
US5462990A (en) 1990-10-15 1995-10-31 Board Of Regents, The University Of Texas System Multifunctional organic polymers
AU2002364607A1 (en) 2001-12-28 2003-07-24 The Burnham Institute Novel ligand involved in the transmigration of leukocytes .
WO2005019429A2 (en) 2003-08-22 2005-03-03 Potentia Pharmaceuticals, Inc. Compositions and methods for enhancing phagocytosis or phagocyte activity
WO2005027965A1 (en) 2003-09-24 2005-03-31 Peter Krammer Antibodies against annexins, use thereof for therapy and diagnosis. use of annexins for therapy and diagnosis.
CA2545166A1 (en) * 2003-11-11 2005-05-19 Chugai Seiyaku Kabushiki Kaisha Humanized anti-cd47 antibody
JP5139058B2 (ja) 2004-06-02 2013-02-06 シドニー キンメル キャンサー センター 新形成または新生脈管構造の検出、画像化および処置のための血管標的
GB0822011D0 (en) 2008-12-02 2009-01-07 Queen Mary & Westfield College Treatment
EP2580241B1 (en) * 2010-06-09 2020-11-04 Queen Mary & Westfield College, University of London Annexin 1 antibody
CN102898527B (zh) 2011-07-25 2016-12-21 三星电子株式会社 融合蛋白、药物组合物及预防或治疗癌症的方法
GB201121561D0 (en) 2011-12-14 2012-01-25 Queen Mary & Westfield College Transgenic animal
GB201121564D0 (en) 2011-12-14 2012-01-25 Queen Mary & Westfield College Use of antibody
KR20150029457A (ko) 2013-09-10 2015-03-18 삼성전자주식회사 아넥신 a1에 결합하는 폴리펩타이드 및 그의 용도

Similar Documents

Publication Publication Date Title
JP2020506715A5 (https=)
RU2019126888A (ru) Антитело к человеческому аннексину а1
JP2020023523A5 (https=)
TWI588155B (zh) 具有人類ox40專一性之抗體分子
RU2495050C2 (ru) Связующий элемент для рецептора gm-csf
CN109311974A (zh) 抗人白细胞介素-17a单克隆抗体、其制备方法和应用
JP2010500876A5 (https=)
ES2822431T3 (es) Polipéptidos de unión a IL-17A
JP2016524463A5 (https=)
IL273841B1 (en) Antibodies targeting cd137 and methods of use thereof
RU2012118636A (ru) Молекула, специфически связывающаяся с rsv
JP2017522903A5 (https=)
HRP20150799T1 (hr) Sastavi i postupci za protutijela protiv komplementnog proteina c5
HRP20191824T1 (hr) Agonistička sredstva za vezivanje tnf receptora
JP2008527989A5 (https=)
TW201233795A (en) Chemokine receptor binding polypeptides
JP2019521647A5 (https=)
JP2023515223A5 (https=)
CN104684929A (zh) 治疗血管疾病及其并发症
JP2016520595A5 (https=)
CN103497253A (zh) 一种针对h2a.z变体的纳米抗体、其编码序列及应用
JP2013531991A5 (https=)
JP2020505465A5 (https=)
CN109897107B (zh) 纳米抗体及其制备方法
CN114591432B (zh) 抗TNFα的单域抗体及其用途